Poly Medicure Ltd Stock Falls to 52-Week Low of Rs 1260.75

Recent Price Movement and Market Context

On the day the new low was recorded, Poly Medicure’s stock touched an intraday low of Rs 1260.75, representing a 4.34% decline from the previous close. The stock’s day change stood at -3.76%, moving in line with the Medical Equipment, Supplies and Accessories sector, which itself fell by 3.83%. This sectoral weakness coincided with a broader market downturn, as the Sensex opened 772.19 points lower and traded at 82,859.83, down 0.97% for the day.

Despite the Sensex being only 3.98% below its 52-week high of 86,159.02, Poly Medicure’s stock has diverged sharply, falling 42.98% over the past year compared to the Sensex’s positive 8.85% return. The stock’s 52-week high was Rs 2936.70, underscoring the extent of the recent decline.

Technical Indicators Reflect Bearish Sentiment

Poly Medicure is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning signals sustained downward momentum. The stock’s relative weakness is further highlighted by its three-day losing streak, which has accelerated the decline in price.

Financial Performance and Valuation Metrics

Poly Medicure’s financial results have contributed to the subdued market sentiment. The company reported a quarterly profit after tax (PAT) of Rs 75.86 crores for the December 2025 quarter, reflecting an 11.0% decline compared to the previous corresponding period. Operating profit margins have also contracted, with the operating profit to net sales ratio falling to a quarterly low of 22.52%.

Additionally, the company’s debtors turnover ratio for the half-year ended was recorded at 4.02 times, the lowest in recent periods, indicating slower collection efficiency. Despite these challenges, Poly Medicure maintains a low average debt-to-equity ratio of zero, signalling a conservative capital structure.

Return on equity (ROE) stands at 12.4%, while the stock trades at a price-to-book value of 4.6, suggesting a relatively expensive valuation compared to its earnings and book value. The PEG ratio is 3.2, reflecting a higher price relative to earnings growth, which has been modest at an annual rate of 17.77% over the last five years for operating profit growth.

Sector Position and Market Capitalisation

With a market capitalisation of Rs 13,358 crores, Poly Medicure is the second largest company in the healthcare services sector, accounting for 11.62% of the sector’s total market value. Its annual sales of Rs 1,781.58 crores represent 17.34% of the industry’s revenue, underscoring its significant presence in the medical equipment and supplies segment.

Institutional investors hold a substantial 23.24% stake in the company, reflecting confidence from entities with extensive analytical resources. However, this has not translated into positive price momentum in recent months.

Comparative Performance and Ratings

Poly Medicure’s performance has lagged behind broader market indices and sector peers. Over the past year, the stock has generated a negative return of 42.97%, underperforming the BSE500 index across multiple time frames including one year, three years, and three months.

MarketsMOJO assigns the stock a Mojo Score of 30.0 and a Mojo Grade of Sell as of 11 Feb 2026, an upgrade from a previous Strong Sell rating. The market cap grade is 3, indicating a mid-tier valuation relative to market capitalisation benchmarks.

Summary of Key Concerns

The stock’s decline to its 52-week low is attributable to a combination of factors including weaker quarterly earnings, contraction in operating margins, and a valuation that remains elevated relative to earnings growth. The company’s slower receivables turnover and underperformance relative to sector peers have also weighed on sentiment.

While the broader healthcare services sector has experienced some downward pressure, Poly Medicure’s share price has declined more sharply, reflecting company-specific challenges amid a cautious market environment.

Market and Sector Outlook

The Sensex’s current position below its 50-day moving average, despite the 50DMA trading above the 200DMA, indicates a mixed market backdrop. The healthcare services sector’s recent decline of 3.83% has contributed to the pressure on stocks like Poly Medicure, which are sensitive to sectoral trends and investor rotation.

Poly Medicure’s sizeable market capitalisation and significant sector weightage mean its price movements have notable implications for the healthcare services index composition and investor portfolios.

Conclusion

Poly Medicure Ltd’s stock reaching a new 52-week low of Rs 1260.75 reflects a period of subdued performance and valuation pressures amid a challenging sector environment. The company’s financial metrics, including declining PAT and operating margins, combined with technical indicators, have contributed to the recent price weakness. Institutional holdings remain significant, but the stock’s underperformance relative to the Sensex and sector peers highlights ongoing headwinds.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →